OCTOBER, 2014 Gene-Related Patent Applications Posted - Full application: http://appft1.uspto.gov/netahtml/PTO/srchnum.html
CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY
Appl Number Title Assignee Date Issued Country
20140322716 Uniquely Tagged Rearranged Adaptive Immune Receptor Genes in a Complex Gene Set Adaptive Biotechnologies Corporation 30-Oct-14 United States
20140315261 METHOD FOR PRODUCING AN L-AMINO ACID USING A BACTERIUM OF THE FAMILY ENTEROBACTERIACEAE HAVING ATTENUATED EXPRESSION OF THE yjjK GENE AJINOMOTO CO., INC. 23-Oct-14 Japan
20140322799 METABOLICALLY ENHANCED CYANOBACTERIUM WITH SEQUENTIALLY INDUCIBLE PRODUCTION GENES FOR THE PRODUCTION OF A FIRST CHEMICAL COMPOUND Algenol Biofuels Inc. 30-Oct-14 United States
20140295489 ORGANIC COMPOUNDS Assaraf; Yehuda G 9-Oct-14 Israel
20140322760 METHOD FOR PRODUCING VIRUS VECTOR FOR GENE TRANSFER BIOCOMO INC. 30-Oct-14 Japan
20140302558 MODIFIED BORDETELLA PERTUSSIS STRAINS BIONET-ASIA, CO. LTD 9-Oct-14 Thailand
20140302501 MUTATION DETECTION IN HIGHLY HOMOLOGOUS GENOMIC REGIONS Canon U.S. Life Sciences, Inc. 9-Oct-14 United States
20140295431 METHOD OF ALLELE-SPECIFIC AMPLIFICATION CLARIENT DIAGNOSTIC SERVICES, INC. 9-Oct-14 United States
20140315193 Kits and Methods for Assessing Antioxidant Requirement of a Human GENELINK, INC. 23-Oct-14 United States
20140315294 SCALABLE LENTIVIRAL VECTOR PRODUCTION SYSTEM COMPATIBLE WITH INDUSTRIAL PHARMACEUTICAL APPLICATIONS GENETHON 23-Oct-14 France
20140322777 PROCESS OF SEPARATING COMPONENTS OF A FERMENTATION BROTH Genomatica, Inc. 30-Oct-14 United States
20140302500 COMPOSITIONS AND METHODS FOR DETECTING BV-ASSOCIATED BACTERIAL NUCLEIC ACID GEN-PROBE INCORPORATED 9-Oct-14 United States
20140302512 GENOTOXICITY TESTING GENTRONIX LIMITED 9-Oct-14 United Kingdom
20140308703 Mammalian Cell Lines for Increasing Longevity and Protein Yield from a Cell Culture IMMUNOMEDICS, INC. 16-Oct-14 United States
20140308665 DIAGNOSIS OF HEREDITARY SPASTIC PARAPLEGIAS (HSP) BY DETECTION OF A MUTATION IN THE KIAA1840 GENE OR PROTEIN Institut National De La Sante Et De La Recherche Medicale 16-Oct-14 France
20140322812 Mutant Receptors and Their Use in a Nuclear Receptor-Based Inducible Gene Expression System Intrexon Corporation 30-Oct-14 United States
20140322789 LINKER-BRIDGED GENE OR DOMAIN FUSION REVERSE TRANSCRIPTASE ENZYME Lee; Jun Euihum 30-Oct-14 United States
20140315199 GENE FUSIONS AND GENE VARIANTS ASSOCIATED WITH CANCER LIFE TECHNOLOGIES CORPORATION 23-Oct-14 Ireland
20140295501 NOVEL METHOD TO LOAD A MAMMALIAN ARTIFICIAL CHROMOSOME WITH MULTIPLE GENES Magyar Tudomanyos Akademia Szegedi Biologiai 9-Oct-14 Hungary
20140308668 Method of Determining Susceptibility of a Tumor Cell to a Chemotherapeutic Agent: Novel Use of Herpes SImplex Virus Medical Diagnostic Laboratories, LLC 16-Oct-14 United States
20140302556 CONTROLLING O-GLYCOSYLATION IN LOWER EUKARYOTES MERCK SHARP & DOHEME CORP. 9-Oct-14 United States
20140315312 MODIFIED GENE SILENCING Monsanto Technology LLC 23-Oct-14 United States
20140302494 METHOD OF ANALYZING A BRCA2 GENE IN A HUMAN SUBJECT Myriad Genetics, Incorporated 9-Oct-14 United States
20140315246 COMPOSITE SUGAR CHAIN HYDROLASE National Institute of Advanced Industrial Science and Technology 23-Oct-14 Japan
20140308675 MUTAGENICITY TEST METHOD USING MAMMALIAN CELLS NISSIN FOODS HOLDINGS CO., LTD 16-Oct-14 Japan
20140308678 SMYD2 AS A TARGET GENE FOR CANCER THERAPY AND DIAGNOSIS ONCOTHERAPY SCIENCE, INC. 16-Oct-14 Japan
20140315234 METHOD TO GENERATE DOPAMINERGIC NEURONS FROM MOUSE AND HUMAN CELLS OSPEDALE SAN RAFFAELE S.R.L. 23-Oct-14 Italy
20140308657 SERINE PROTEASE INHIBITOR KAZAL ANTIBODIES Philadelphia Health & Education Corporation d/b/a Drexel University College of Medicine 16-Oct-14 United States
20140315208 METHOD FOR PREDICTING RISK OF PORENCEPHALY OR CEREBRAL HEMORRHAGE Public University Corporation Yokohama City Univer 23-Oct-14 Japan
20140315257 GENE TARGETING VECTOR, METHOD FOR MANUFACTURING SAME, AND METHOD FOR USING SAME PUBLIC UNIVERSITY CORPORATION YOKOHAMA CITY UNIVERSITY 23-Oct-14 Japan
20140295457 GENE CLUSTER FOR BIOSYNTHESIS OF GRISELIMYCIN AND METHYLGRISELIMYCIN SANOFI 9-Oct-14 France
20140295496 RECOMBINANT BACULOVIRUS AND USE THEREOF SYSMEX CORPORATION 9-Oct-14 Japan
20140315198 DACH1 AS A BIOMARKER FOR DIABETES The Chinese University of Hong Kong 23-Oct-14 Hong Kong
20140295448 SUPPRESSION OF TLA2-CpFTSY GENE EXPRESSION FOR IMPROVED SOLAR ENERGY CONVERSION EFFICIENCY AND PHOTOSYNTHETIC PRODUCTIVITY IN ALGAE THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 9-Oct-14 United States
20140308731 Novel Cytochrome P450 Enzymes From Sorghum Bicolor the Secretary of Agriculture; The United States of America 16-Oct-14 United States
20140322717 SELECTIVE AMPLIFICATION AND DETECTION OF MUTANT GENE ALLELES THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK 30-Oct-14 United States
20140295456 RENAL CELL CARCINOMA BIOMARKERS The United States of America, as represented by the Secretary, Department of Health and Human Serv 9-Oct-14 United States
20140295425 Diagnosis for Alzheimer's Disease The University of Birmingham 9-Oct-14 United Kingdom
20140295427 FIBROSIS SUSCEPTIBILITY IL22RA2 GENE AND USES THEREOF UNIVERSITE D'AIX-MARSEILLE 9-Oct-14 France
20140315210 METHODS RELATING TO IDIOPATHIC PULMONARY FIBROSIS (IPF) University College Dublin, National University of Ireland, Dublin 23-Oct-14 Irreland
20140322813 METHODS AND COMPOSITIONS FOR ENHANCING THE EFFICACY AND SPECIFICITY OF RNA SILENCING UNIVERSITY OF MASSACHUSETTS 30-Oct-14 United States
20140302547 METHODS OF ISOLATING BIPOTENT HEPATIC PROGENITOR CELLS University of North Carolina at Chapel Hill 9-Oct-14 United States
20140302577 ENHANCED YEAST FERMENTATION PLATFORM USING YEAST LACKING MITOCHONDRIAL DNA AND CONTAINING GROWTH IMPROVING MUTATIONS UNIVERSITY OF WYOMING 9-Oct-14 United States
20140308715 MICROBIAL CONVERSION OF SUGAR ACIDS AND MEANS THEREIN Valtion Teknillinen Tutkimuskesus 16-Oct-14 United States
20140308660 METHOD FOR DISCRIMINATION OF METAPLASIAS FROM NEOPLASTIC OR PRENEOPLASTIC LESIONS Ventana Medical Systems, Inc. 16-Oct-14 United States
20140308704 ADENOVIRUS PRODUCING NOVEL CELL LINE AND THE USE THEREOF VIROMED CO., LTD 16-Oct-14 Korea
20140315301 ISOLATED NAIVE PLURIPOTENT STEM CELLS AND METHODS OF GENERATING SAME Yeda Research and Development Co. Ltd. 23-Oct-14 Israel
20140295507 METHOD FOR PRODUCING BIODEGRADABLE POLYMER AND BIOMASS FUEL CONVERTED FROM CARBON SOURCE BY RECOMBINANT MICROORGANISMS Yuan Ze University 9-Oct-14 Taiwan
COMBINATORIAL CHEMISTRY TECHNOLOGY
Appl Number Title Assignee Date Issued Country
20140323318 METHODS OF DETECTING MUTATIONS ASSOCIATED WITH ATAXIA-OCULAR APRAXIA 2 (AOA2) Athena Diagnostics, Inc. 30-Oct-14 United States
20140323320 METHOD OF DETECTING FUSED TRANSCRIPTS AND SYSTEM THEREOF BGI TECH SOLUTIONS CO., LTD. 30-Oct-14 China P Repub
20140303031 METHODS AND COMPOSITIONS FOR CHARACTERIZING AUTISM SPECTRUM DISORDER BASED ON GENE EXPRESSION PATTERNS Children's Medical Center Corporation 9-Oct-14 United States
20140296100 METHODS FOR TREATING CANCER RESISTANT TO ERBB THERAPEUTICS Dana Farber Cancer Institute 9-Oct-14 United States
20140323331 BIOMARKERS FOR DIAGNOSIS AND TREATMENT OF ACNE VULGARIS DermTech International 30-Oct-14 United States
20140296104 Genes Differentially Expressed by Cumulus Cells and Assays Using Same to Identify Pregnancy Competent Oocytes GEMA DIAGNOSTICS, INC 9-Oct-14 United States
20140315744 ASSESSMENT OF OOCYTE COMPETENCE BY DETECTING SPSB2 AND/OR TP53I3 GENE EXPRESSION Gema Diagnostics, Inc. 23-Oct-14 United States
20140303002 Gene Expression Profile Algorithm and Test for Determining Prognosis of Prostate Cancer Genomic Health, Inc. 9-Oct-14 United States
20140315758 CANCER ANTIGEN-SPECIFIC T-CELL RECEPTOR GENE, PEPTIDE ENCODED BY THE GENE, AND USE OF THEM International Institute of Cancer Immunology, Inc. 23-Oct-14 Japan
20140315735 CANCER ANTIGEN-SPECIFIC T-CELL RECEPTOR GENE, PEPTIDE ENCODED BY THE GENE, AND USE OF THEM International Institute of Cancer Immunology, Inc. 23-Oct-14 Japan
20140303028 GENOMIC DIAGNOSTICS USING CIRCULATING ENDOTHELIAL CELLS Janssen Diagnostics, LLC 9-Oct-14 United States
20140323327 ANIMALS, REPERTOIRES & METHODS Kymab Limited 30-Oct-14 United Kingdom
20140323345 NOVEL MARKERS OF PAPILLARY AND RETICULAR FIBROBLASTS AND USES THEREOF LEIDEN UNIVERSITY MEDICAL CENTER 30-Oct-14 Netherlands
20140303038 3' Biased Detection of Nucleic Acids LIFE TECHNOLOGIES CORPORATION 9-Oct-14 United States
20140323329 Gene Fusion LIFE TECHNOLOGIES CORPORATION 30-Oct-14 United States
20140296086 SYSTEM AND METHOD FOR CELL-TYPE SPECIFIC COMPARATIVE ANALYSES OF DIFFERENT GENOTYPES TO IDENTIFY RESISTANCE GENES MISSISSIPPI STATE UNIVERSITY 9-Oct-14 United States
20140309122 KNOWLEDGE-DRIVEN SPARSE LEARNING APPROACH TO IDENTIFYING INTERPRETABLE HIGH-ORDER FEATURE INTERACTIONS FOR SYSTEM OUTPUT PREDICTION NEC Laboratories America, Inc. 16-Oct-14 United States
20140309137 GENE EXPRESSION PROFILES ASSOCIATED WITH LEAN PHENOTYPE AND USES THEREOF NESTEC SA 16-Oct-14 Switzerland
20140323349 COMPOSITIONS AND METHODS FOR MONITORING AND DETECTING CANCEROUS CONDITIONS PHIGENIX, INC. 30-Oct-14 United States
20140296103 TOPOGRAPHIC GENOTYPING FOR DETERMINING THE DIAGNOSIS, MALIGNANT POTENTIAL, AND BIOLOGIC BEHAVIOR OF PANCREATIC CYSTS AND RELATED CONDITIONS Redpath Integrated Pathology, Inc. 9-Oct-14 United States
20140323344 Differential Identification of Pancreatic Cysts THE JOHNS HOPKINS UNIVERSITY 30-Oct-14 United States
20140303020 Method for Assessing Myelodysplastic Syndrome or Myeloid Tumor Predisposition, Polypeptide and Antibody Therefor, and Candidate Screening Method for Therapeutic Drug or Prophylactic Drug Therefor The University of Tokyo 9-Oct-14 Japan
20140309142 METHOD OF ON-CHIP NUCLEIC ACID MOLECULE SYNTHESIS TIAN; Jingdong 16-Oct-14 United States
20140315737 BIOMARKERS FOR EPILEPSY UCB PHARMA, S.A. 23-Oct-14 Belgium
20140303029 GENETIC ALTERATIONS IN GLIOMA UNIVERSITY OF UTAH RESARCH 9-Oct-14 United States
20140323335 Methods of Novel Therapeutic Candidate Identification Through Gene Expression Analysis in Vascular-Related Diseases Vascular Biosciences 30-Oct-14 United States
DATA PROCESSING
Appl Number Title Assignee Date Issued Country
20140303901 METHOD AND SYSTEM FOR PREDICTING A DISEASE SADEH; Ilan 9-Oct-14 Israel
20140304290 SCREENING TOOL FOR PROVIDERS OF SYNTHETIC DOUBLE STRANDED DNA UT-BATELLE, LLC 9-Oct-14 United States
20140297194 GENE SIGNATURES FOR DETECTION OF POTENTIAL HUMAN DISEASES Yang; Yih-Sheng 9-Oct-14 United States
DRUG
Appl Number Title Assignee Date Issued Country
20140296129 REGULATION OF RECEPTOR EXPRESSION THROUGH DELIVERY OF ARTIFICIAL TRANSCRIPTION FACTORS ALIOPHTHA AG 9-Oct-14 Switzerland
20140315835 RNAI AGENTS, COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING TRANSTHYRETIN (TTR) ASSOCIATED DISEASES ALNYLAM PHARMACEUTICALS, INC. 23-Oct-14 United States
20140294936 Compositions And Methods For Inhibiting Expression Of The HAMP Gene Alnylam Pharmaceuticals, Inc. 9-Oct-14 United States
20140314798 METHOD TO MEASURE INFLAMMATION IN THE CONJUNCTIVA OF PATIENTS WITH TEAR DYSFUNCTION BAYLOR COLLEGE OF MEDICINE 23-Oct-14 United States
20140294924 Regeneration of Pancreatic Islets and Reversal of Diabetes by Islet Transcription Factor Genes Delivered In Vivo Baylor Research Institute 9-Oct-14 United States
20140322223 TOX3 AS A BIOMARKER FOR BREAST CANCER CEDARS-SINAI MEDICAL CENTER 30-Oct-14 United States
20140315844 MULTI-GENE SIGNATURES FOR PREDICTING RESPONSE TO CHEMOTHERAPY OR RISK OF METASTASIS FOR BREAST CANCER Celera Corporation 23-Oct-14 United States
20140314765 SIGNATURES AND DETERMINANTS ASSOCIATED WITH PROSTATE CANCER PROGRESSION AND METHODS OF USE THEREOF DANA-FARBER CANCER INSTITUTE, INC. 23-Oct-14 United States
20140302042 METHODS OF PREDICTING PROGNOSIS IN CANCER DANA-FARBER CANCER INSTITUTE, INC. 9-Oct-14 United States
20140314791 METHODS OF TREATING CANCER DANA-FARBER CANCER INSTITUTE, INC. 23-Oct-14 United States
20140322255 SECOND GENERATION VIRUS-LIKE PARTICLES (VLP) FROM EPSTEIN-BARR VIRUSES FOR VACCINATION PURPOSES Deutsches Krebsforschungszentrum 30-Oct-14 Germany
20140309177 COMPOSITIONS AND METHODS FOR THE INDUCTION AND TUNING OF GENE EXPRESSION Duke University 16-Oct-14 United States
20140294772 THYMIDINE KINASE DIAGNOSTIC ASSAY FOR GENE THERAPY APPLICATIONS Epeius Biotechnologies Corporation 9-Oct-14 United States
20140308261 HLA-DR7 HY epitope and method for treating leukaemia Etablissement Francais du Sang 16-Oct-14 France
20140309290 METHOD OF GENE TRANSFER FOR THE TREATMENT OF RECESSIVE CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA (CPVT) Fondazione Salvatore Maugeri Clinica Del Lavoro E Della Riabilitazione 16-Oct-14 Italy
20140302171 Cysteine Peptide-Containing Health Drink For Days Co., Ltd 9-Oct-14 Japan
20140309186 Metabolomics-Based Identification of Disease-Causing Agents Georgia Tech Research Corporation 16-Oct-14 United States
20140308248 Dietary Supplement System for Multifunctional Anti-Aging Management and Method of Use Giampapa; Vincent C. 16-Oct-14 United States
20140314757 PHYTOCANNABINOIDS FOR USE IN THE TREATMENT OF BREAST CANCER GW Pharma Limited 23-Oct-14 United Kingdom
20140294811 METHOD FOR PREDICTING RISK OF HYPERTENSION ASSOCIATED WITH ANTI-ANGIOGENESIS THERAPY Hoffmann-La Roche Inc. 9-Oct-14 United States
20140294768 RESPONSIVENESS TO ANGIOGENESIS INHIBITORS Hoffmann-La Roche Inc. 9-Oct-14 United States
20140308275 METHODS FOR DIAGNOSING AND TREATING MYHRE SYNDROME INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE 16-Oct-14 France
20140322184 INDUCIBLE EXPRESSION CASSETTE, AND USES THEREOF INSTITUT NATIONAL DE LA RECHERCHE 30-Oct-14 France
20140294893 RECOMBINANT NONPATHOGENIC MDV VECTOR PROVIDING MULTIVALENT IMMUNITY INTERVET INTERNATIONAL B.V. 9-Oct-14 Netherlands
20140308247 Vectors Conditionally Expressing Protein Intrexon Corporation 16-Oct-14 United States
20140309281 MULTI-CONJUGATE OF SIRNA AND PREPARING METHOD THEREOF KAIST IP Co. Ltd. 16-Oct-14 Korea
20140294806 Methods and compositions for treating cancers having acquired resitance to prior chemotherapeutic and targeted drugs using carboxyamidotriazole orotate Karmali; Rashida A 9-Oct-14 United States
20140303198 AGENT FOR INHIBITING EXPRESSION OF NPC1L1 AND/OR LIPG MRNA AND AGENT FOR PREVENTING AND/OR TREATING OBESITY KOWA COMPANY, LTD. 9-Oct-14 Japan
20140294957 NICLOSAMIDE FOR THE TREATMENT OF CANCER METASTASIS MAXDELBRUCK-CENTRUM FUR MOLEKULARE MEDIZIN 9-Oct-14 Germany
20140294941 ANTI-ANGIOGENIC COMPOSITIONS AND THERAPEUTIC APPLICATIONS THEREOF Medestea Research & Production S.P.A. 9-Oct-14 Italy
20140323546 PME-1 AS A BIOMARKER TO PREDICT AND DIAGNOSE AN INCREASED RISK OF ENDOMETRIAL CANCER AND GENE SILENCING OF PME-1 TO INHIBIT EPITHELIAL TO MESENCHYMAL TRANSITION MEDICAL DIAGNOSTIC LABORATORIES, LLC 30-Oct-14 United States
20140322169 Recombinant Virus Products and Methods for Inhibition of Expression of DUX4 NATIONWIDE CHILDREN'S HOSPITAL, INC. 30-Oct-14 United States
20140294927 SYNTHETIC NANOSTRUCTURES INCLUDING NUCLEIC ACIDS AND/OR OTHER ENTITIES Northwestern University 9-Oct-14 United States
20140309240 DERIVATIVES OF 1-(SUBSTITUTED SULFONYL)-2-AMINOIMIDAZOLINE AS ANTITUMOR AND ANTIPROLIFERATIVE AGENTS OncoArendi Therapeutics Sp. z o.o. 16-Oct-14 Poland
20140309259 DERIVATIVES OF 1-(SUBSTITUTED SULFONYL)-2-AMINOIMIDAZOLINE AS ANTITUMOR AND ANTIPROLIFERATIVE AGENTS OncoArendi Therapeutics Sp. z.o.o. 16-Oct-14 Poland
20140315982 DOUBLE-STRANDED NUCLEIC ACID MOLECULE FOR GENE EXPRESSION CONTROL Osaka City University 23-Oct-14 Japan
20140302100 METHODS AND BIOMARKERS FOR ANALYSIS OF COLORECTAL CANCER OSLO UIVERSITETSSYKEHUS HF 9-Oct-14 Norway
20140309199 9-AMINOMETHYL SUBSTITUTED MINOCYCLINE COMPOUNDS Paratek Pharmaceuticals, Inc. 16-Oct-14 United States
20140302178 Natural Product for Decreasing Symptoms During Viral Infections Polansky; Hanan 9-Oct-14 United States
20140322237 NEURODEGENERATIVE DISEASES AND METHODS OF MODELING President and Fellows of Harvard College 30-Oct-14 United States
20140309264 ACYLAMINO-SUBSTITUTED FUSED CYCLOPENTANECARBOXYLIC ACID DERIVATIVES AND THEIR USE AS PHARMACEUTICALS SANOFI 16-Oct-14 France
20140323544 EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY SAREPTA THERAPEUTICS, INC. 30-Oct-14 United States
20140315977 EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY SAREPTA THERAPEUTICS, INC. 23-Oct-14 United States
20140315862 COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY Sarepta Therapeutics, Inc. 23-Oct-14 United States
20140302155 PRODUCTION OF A HUMAN BETA CELL LINE FROM AN EARLY POST NATAL PANCREAS SARL ENDOCELLS 9-Oct-14 France
20140296320 Use Of siRNA To Achieve Down Regulation Of An Endogenous Gene In Combination With The Use of A Sense Construct To Achieve Expression Of A Polynucleotide SENESCO TECHNOLOGIES, INC. 9-Oct-14 United States
20140309232 BIOENGINEERING STRAIN FOR PRODUCTION OF NOVEL MICROORGANISM-ORIGINATED FUNGICIDES AND USES THEREOF SHANGHAI JIAOTONG UNIVERSITY 16-Oct-14 China P Repub
20140302181 DRUG SCREENING METHOD, DRUGS PROMOTING EXTRACELLULAR MATRIX CROSSLINKING AND THE APPLICATIONS THEREOF SHANGHAI TENTH PEOPLE'S HOSPITAL 9-Oct-14 China P Reo\p.
20140294940 MRNA THERAPY FOR UREA CYCLE DISORDERS Shire Human Genetic Therapies, Inc. 9-Oct-14 United States
20140314812 LIVE, ATTENUATED STREPTOCOCCUS PNEUMONIAE STRAIN AND VACCINE FOR PROTECTION AGAINST PNEUMOCOCCAL DISEASE St. Jude Children's Research Hospital 23-Oct-14 United States
20140296248 METHODS AND COMPOSITIONS FOR PREDICTING RESISTANCE TO ANTICANCER TREATMENT Stichting het Nederlands Kanker Instiuut-Antoni van Leeuwenhoek ziekenhuis 9-Oct-14 Netherlands
20140323556 SCALABLE MANUFACTURING PROCESS TO PRODUCE RECOMBINANT LENTIVIRAL VECTORS IN SERUM-FREE SUSPENSION CELL CULTURE SYSTEM THE CHILDREN'S HOSPITAL OF PHILADELPHIA 30-Oct-14 United States
20140309288 GENE THERAPY INDUCED PYROPTOSIS FOR THE TREATMENT OF TUMORS THE GENERAL HOSPITAL CORPORATION 16-Oct-14 United States
20140296141 Compositions and Methods for Treating Obesity, Obesity Related Disorders and for Inhibiting the Infectivity of Human Immunodeficiency Virus The General Hospital Corporation 9-Oct-14 United States
20140301943 INDUCTION OF THYROID IODIDE-HANDLING GENE EXPRESSION IN HUMAN CANCERS The Johns Hopkins University 9-Oct-14 United States
20140294771 Adeno-Associated Virus Virions with Variant Capsid and Methods of Use Thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 9-Oct-14 United States
20140309289 COMBINATION ANTI-HIV VECTORS, TARGETING VECTORS, AND METHODS OF USE The Regents of the University of California 16-Oct-14 United States
20140322249 DNA VACCINES AGAINST TUMOR GROWTH AND METHODS OF USE THEREOF The Scripps Research Institute 30-Oct-14 United States
20140322243 METHODS OF DETECTING BREAST CANCER BRAIN METASTASIS WITH GENOMIC AND EPIGENOMIC BIOMARKERS THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE 30-Oct-14 United States
20140296326 EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) AND METHODS OF USE IN ADENOVIRAL-ASSOCIATED VIRUS TYPE 6 (AAV6) TRANSDUCTION The United States of America 9-Oct-14 United States
20140315987 CHOLECYSTOKININ B RECEPTOR (CCKBR) MINI-PROMOTERS The University of British Columbia 23-Oct-14 Canada
20140309285 ANTISENSE OLIGONUCLEOTIDES FOR INDUCING EXON SKIPPING AND METHODS OF USE THEREOF THE UNIVERSITY OF WESTERN AUSTRALIA 16-Oct-14 Australia
20140309284 ANTISENSE OLIGONUCLEOTIDES FOR INDUCING EXON SKIPPING AND METHODS OF USE THEREOF THE UNIVERSITY OF WESTERN AUSTRALIA 16-Oct-14 Australia
20140309283 ANTISENSE OLIGONUCLEOTIDES FOR INDUCING EXON SKIPPING AND METHODS OF USE THEREOF THE UNIVERSITY OF WESTERN AUSTRALIA 16-Oct-14 Australia
20140314712 FUSION PROTEIN COMPRISING AN INTERLEUKIN 4 AND INTERLEUKIN UMC Utrecht Holding B.V. 23-Oct-14 United States
20140294785 DOSAGE COMPENSATING TRANSGENES AND CELLS UNIVERSITY OF MASSACHUSETTS 9-Oct-14 United States
20140296324 VECTORS HARBORING TOXIC GENES, METHODS AND USES THEREFOR Virovek Incorporation 9-Oct-14 United States
20140294773 MODIFIED CASCADE RIBONUCLEOPROTEINS AND USES THEREOF WAGENINGEN UNIVERSITEIT 9-Oct-14 United States
20140302077 LIVE ATTENUATED INFLUENZA VIRUS Westfaelische Wilhelms-Universitaet Munester 9-Oct-14 Germany
20140314750 Six-Gene Biomarker of Survival and Response to Platinum Based Chemotherapy in Serious Ovarian Cancer Patients Wisconsin Alumni Research Foundation 23-Oct-14 United States
INFORMATION SECURITY
Appl Number Title Assignee Date Issued Country
20140325625 CYBER GENE IDENTIFICATION TECHNOLOGY BASED ON ENTITY FEATURES IN CYBER SPACE Liu; Nanjie 30-Oct-14 China P Repub
MULTICELLULAR LIVING ORGANISMS
Appl Number Title Assignee Date Issued Country
20140298541 ISOLATED POLYNUCLEOTIDES EXPRESSING OR MODULATING dsRNAs, TRANSGENIC PLANTS COMPRISING SAME AND USES THEREOF IN IMPROVING NITROGEN USE EFFICIENCY, ABIOTIC STRESS TOLERANCE, BIOMASS, VIGOR OR YIELD OF A PLANT A.B. Seeds Ltd. 9-Oct-14 Israel
20140317781 ISOLATED POLYNUCLEOTIDES AND POLYPEPTIDES, TRANSGENIC PLANTS COMPRISING SAME AND USES THEREOF IN IMPROVING ABIOTIC STRESS TOLERANCE, NITROGEN USE EFFICIENCY, BIOMASS, VIGOR OR YIELD OF PLANTS A.B. Seeds Ltd. 23-Oct-14 Israel
20140298494 ANIMAL MODEL OF AUTISM Beth Israel Deaconess Medical Center, Inc. 9-Oct-14 United States
20140325692 BLUE-LIGHT INDUCIBLE SYSTEM FOR GENE EXPRESSION BOARD OF REGENTS, THE UNIVERSITY OF TEXAS 30-Oct-14 United States
20140325702 Methods for genetic control of plant pest infestation and compositions thereof Boukharov; Andrey A. 30-Oct-14 United States
20140310829 MODIFIED PARVOVIRUS USEFUL FOR GENE SILENCING DEUTSCHES KREBSFORSCHUNGSZENTRUM 16-Oct-14 Germany
20140304856 PLANT SEEDS WITH ALTERED STORAGE COMPOUND LEVELS, RELATED CONSTRUCTS AND METHODS INVOLVING GENES ENCODING PAE AND PAE-LIKE POLYPEPTIDES E I DU PONT DE NEMOURS AND COMPANY 9-Oct-14 United States
20140325697 Glyphosate tolerant corn event VCO-O1981-5 and kit and method for detecting the same Genective 30-Oct-14 France
20140298533 HIGHLY GLYPHOSATE-RESISTANT MUTATED GENE, METHOD OF MODIFICATION AND USE THEREOF HANGZHOU RUIFENG BIOTECHNOLOGY LIMITED INC. 9-Oct-14 China P Reo\p.
20140304846 GENE AND MUTATIONS THEREOF ASSOCIATED WITH SEIZURE AND MOVEMENT DISORDERS ITEK VENTURES PTY LTD 9-Oct-14 Auaatralia
20140317767 Persistent Inheritance of Hyperdominant Traits in a Perennial Lineage Meadow, JR.; William Douglas 23-Oct-14 United States
20140304845 ALZHEIMER'S DISEASE SIGNATURE MARKERS AND METHODS OF USE MERCK SHARP & DOHME CORP 9-Oct-14 United States
20140317780 TEMPORAL REGULATION OF GENE EXPRESSION BY MICRORNAS Monsanto Technology LLC 23-Oct-14 United States
20140325710 Genes and uses for plant improvement Monsanto Technology LLC 30-Oct-14 United States
20140325700 THIFENSULFURON HYDROLASE GENE TSME AND USES THEREOF NANJING AGRICULTURAL UNIVERSITY 30-Oct-14 China P Repub
20140298544 Engineered PEP carboxylase variants for improved plant productivity PIONEER HI BRED INTERNATIONAL INC 9-Oct-14 United States
20140317788 Non-Transgenic Tomato Varieties Having Increased Shelf Life Post-Harvest rcadia Biosciences, Inc. 23-Oct-14 United States
20140317787 Non-Transgenic Tomato Varieties Having Increased Shelf Life Post-Harvest rcadia Biosciences, Inc. 23-Oct-14 United States
20140317782 HIGH TEMPERATURE RESISTANT PLANT GENE AND USE THEREOF SHANGHAI INSITITUTE FOR BIOLOGICAL SCIENCES, CHINSE ACADEMY OF SCIENCES 23-Oct-14 China P Repub
20140298504 TRANSGENIC CHICKENS WITH AN INACTIVATED ENDOGENOUS GENE LOCUS SYNAGEVA BIOPHARMA CORP. 9-Oct-14 United States
20140298537 Crop Resistance to Nematodes The Curators of the University of Missouri Office of Technology and Special Projects 9-Oct-14 United States
20140304852 NOVEL PPETAC1 GENE AND METHOD TO MANIPULATE TREE ARCHITECTURE The United States of America, as represented by the Secretary of Agriculture 9-Oct-14 United States
20140298546 PRODUCTION OF HYBRID LACTUCA SATIVA SEEDS VILMORIN 9-Oct-14 France
20140317785 SPECIFIC GENETIC MODIFICATION OF THE ACTIVITY OF TREHALOSE-6-PHOSPHATE SYNTHASE AND EXPRESSION IN A HOMOLOGOUS OR HETEROLOGOUS ENVIRONMENT Vlaams Interuniversitair Instituut Voor Biotechnologie 23-Oct-14 Belgium
NATURAL RESINS OR DERIVATIVES
Appl Number Title Assignee Date Issued Country
20140296486 NOVEL AAV'S AND USES THEREOF University of Massachusetts 9-Oct-14 United States
ORGANIC COMPOUNDS
Appl Number Title Assignee Date Issued Country
20140296503 ISOLATED dsRNA MOLECULES AND METHODS OF USING SAME FOR SILENCING TARGET MOLECULES OF INTEREST A.B. SEEDS LTD. 9-Oct-14 Israel
20140316123 ENA NUCLEIC ACID PHARMACEUTICALS CAPABLE OF MODIFYING SPLICING OF mRNA PRECURSORS DAIICHI SANKYO COMPANY, LIMITED 23-Oct-14 Japan
20140316125 TRUNCATED CD20 PROTEIN, DELTACD20 ETABLISSEMENT FRANCAIS DU SANG 23-Oct-14 France
20140316126 RNA MOLECULES AND USES THEREOF Mina Therapeutics Limited 23-Oct-14 United Kingdom
20140323709 OLIGONUCLEOTIDE AND THERAPEUTIC AGENT FOR HYPERLIPIDEMIA CONTAINING SAME AS ACTIVE INGREDIENT National Cerebral and Cardiovascular Center 30-Oct-14 Japan
PLANT PROTECTING AND REGULATING COMPOSITIONS
Appl Number Title Assignee Date Issued Country
20140323305 Use of Strobilurin Type Compounds for Combating Phytopathogenic Fungi Resistant to QO Inhibitors BASF SE 30-Oct-14 Germany
SURGERY
Appl Number Title Assignee Date Issued Country
20140323956 RECOMBINANT ADENO-ASSOCIATED VIRUS DELIVERY OF ALPHA-SARCOGLYCAN POLYNUCLEOTIDES NATIONWIDE CHILDREN'S HOSPITAL, INC. 30-Oct-14 United States
20140309486 RECOVERY AND PROCESSING OF HUMAN EMBRYOS FORMED IN VIVO PREVIVO GENETICS, LLC 16-Oct-14 United States
20140303546 LASER ASSISTED DELIVERY OF FUNCTIONAL CELLS, PEPTIDES AND NUCLEOTIDES University of Miami 9-Oct-14 United States
TOBACCO
Appl Number Title Assignee Date Issued Country
20140311502 Tobacco With Reduced Cadmium Content Societe nationale D'Exploitation Industrielle des Tabacs et Allumettes-S.E.I.T.A. 23-Oct-14 France
Bookmark and Share

Login



alta vista babel fish
To traslate this page, click a flag!
flag flag flag flag flag flag flag flag

Advertisements

Eden's Bounty Multi-SanTM
Colorless, odorless, biodegradable instant sanitizer is effective against both gram positive and gram-negative bacteria; kills in 30 seconds. Free of chlorine and quaternary ammonium compounds. EPA registered food contact surface sanitizer. Austin Davis Industries, Inc.
TERRA+ CLEAN Acid-Replacement Surface Cleaner
Safe, totally natural, 100% biodegradable, multi-functional cleaning product providing safety in the workplace for both humans and environmental surfaces - without compromising performance. Can be diluted up to 25:1. Austin Davis Industries, Inc.